PLC supports the Regulatory filings and clinical trials (set-up, site management, data management, etc) and received Fast Track Designation for ARS-1. ARS Pharmaceuticals Announces New Patent on ARS-1 (epinephrine nasal spray) Patent approval covers fast-acting decreased dosage level for intranasal administration for type 1 allergic reaction. SAN DIEGO (July 13, 2020) – ARS Pharmaceuticals today

Pacific Link Consulting’s regulatory support and DMF file management culminated in Aegis being awarded the US Patent for the formula of delivery method of their Intravail® formulation. Aegis is Awarded US Patent for Formulation and Non-invasive Delivery of Peptide Drugs SAN DIEGO, CA August 15, 2018/NASDAQ — Aegis Therapeutics LLC announced today that it has